BERLIN (Reuters) - Victims of thalidomide said on Saturday an apology from the German inventor of the drug that caused birth defects in thousands of babies around the world was too little too late.

LONDON (Reuters) - Half a century after the launch of the notorious morning sickness pill thalidomide, its surviving victims are demanding 4 billion euros ($6.3 billion) in compensation from the ...

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...

More than five decades on, the battle for justice over birth defects caused by the drug thalidomide continues in only one European country: Spain. Spanish victims of thalidomide are the only ones ...

Thalidomide was originally marketed in several countries as a morning sickness drug by Chemie Grünenthal in the late 1950s and early 1960s until its use was linked to thousands of deaths and birth ...

This year marked two important anniversaries in the regulatory community. In the US, regulators noted the 50 th anniversary of the passage of the Kefauver-Harris Amendments to the Federal Food, Drug ...

You have reached your maximum number of saved items. Remove items from your saved list to add more. BRITAIN has issued a long-awaited expression of regret over the drug scandal that left hundreds of ...

Payments made from a trust to victims of thalidomide are to be tax-free, the government has announced. The Treasury said the move would be worth £1m a year in lower tax and increased tax credits for ...

The Government is to apologise to the victims of the thalidomide scandal after agreeing a £20 million support package. Health Minister Mike O'Brien will make the formal apology in an oral statement to ...

BERLIN (AP) -- 1946— Gruenenthal, a German pharmaceutical, is founded in Stolberg. 1954 — Gruenenthal discovers and patents thalidomide. 1957 — Thalidomide is first sold as Contergan in Germany. It is ...